John Moriarity is Vice President, Business Development at Prolytix. He is responsible for building out a commercial organization that will focus on growing new relationships and forging deeper partnerships with our existing clients to position Prolytix as a leader in the large molecule CRO space.
John is building off his experience as Director of Business Development at BioAgilytix, a premier large molecule BioAnalytical CRO, where he contributed to the growth and strategy of the commercial team. Prior to BioAgilytix, John spent 8 years at Covance in which he came up through various lab operational roles before joining their commercial team. John started his career focusing on immunology at the Centers for Disease Control. He spent 7 years in industry working in large and small molecule development for both Merck and Johnson and Johnson.
John has a bachelor’s degree (B.S.) in Biochemistry from Kennesaw State University.